|
FOR IMMEDIATE
RELEASE
Contact:
communications@nof.org
Following is a
Statement by the National Osteoporosis
Foundation on the U.S. Food and Drug
Administration’s Approval of Reclast®
August 21, 2007 –
Osteoporosis is a serious, widespread
and growing public health threat,
according to the National Osteoporosis
Foundation (NOF). NOF welcomes any new
FDA approved treatment options, such as Reclast®, that will help
patients address this prevalent
disease. NOF estimates 10 million
Americans age 50 and older have
osteoporosis and another 34 million are
at risk for the disease.
About NOF:
Established in 1984, the National
Osteoporosis Foundation is the nation’s
leading voluntary health organization
solely dedicated to osteoporosis and
bone health. Our mission is to prevent
osteoporosis, to promote lifelong bone
health, to help improve the lives of
those affected by osteoporosis and
related fractures, and to find a cure.
# # #
Back to
the Press Release Index |
